HIIFS
TARO

Harel Insurance Investments & Financial Services’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-347
Closed -$15K – 587
2024
Q1 		$15K Sell
347
-50
-13% -$2.11K ﹤0.01% 462
2023
Q4 		$17K Sell
397
-167
-30% -$6.16K ﹤0.01% 512
2023
Q3 		$21K Sell
564
-120
-18% -$4.5K ﹤0.01% 546
2023
Q2 		$26K Sell
684
-500
-42% -$15.7K ﹤0.01% 551
2023
Q1 		$29K Buy
1,184
+501
+73% +$14.6K ﹤0.01% 559
2022
Q4 		$20K Sell
683
-50
-7% -$1.48K ﹤0.01% 572
2022
Q3 		$21K Sell
733
-49
-6% -$1.69K ﹤0.01% 595
2022
Q2 		$28K Sell
782
-45
-5% -$1.72K ﹤0.01% 605
2022
Q1 		$36K Sell
827
-69
-8% -$3.22K ﹤0.01% 573
2021
Q4 		$45K Buy
+896
New +$50.2K ﹤0.01% 604

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return
GCM
Gladius Capital Management Chicago, Illinois $1.65B AUM 25.75% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Harel Insurance Investments & Financial Services's TARO Position: Q2 2024 in Review

Harel Insurance Investments & Financial Services sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2024, closing a stake of 347 shares — an estimated $15K sold.

Harel Insurance Investments & Financial Services first reported a position in TARO in Q4 2021 and held it in 10 quarters. The position peaked at $45K in Q4 2021. 16 funds tracked by Wall St. Rank hold TARO as of Q2 2024.

  • Harel Insurance Investments & Financial Services reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2024 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 347 Taro Pharmaceutical Industries Ltd. shares in Q2 2024, an estimated $15K.
  • Harel Insurance Investments & Financial Services first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2021 and held it in 10 quarters.
  • Harel Insurance Investments & Financial Services's Taro Pharmaceutical Industries Ltd. position peaked at $45K in Q4 2021.
  • 16 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2024.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q2 2024, filed 22 Jul 2024.